Terray Therapeutics just launched EMMI, an AI platform that’s turning chemistry’s “impossible” into tomorrow’s drug candidates. Grateful to power their breakthroughs with Lambda’s 1-Click Clusters.
Today we're excited to introduce EMMI, our chemistry-first, AI-native small molecule drug discovery platform. Why EMMI? Because we believe novel discoveries happen at the place where Experimentation Meets Machine Intelligence. EMMI is more than a name, it’s our commitment to improve human health by transforming the speed, cost, and success rate of small molecule drug discovery and development using computation integrated with novel data at scale. Starting from scratch, EMMI has delivered structurally novel molecules to address challenging targets across Terray’s diverse pipeline. We can’t wait to see EMMI’s innovations transform the lives of patients in need! Go in-depth https://lnkd.in/gfmchNXF